Kaitlyn D’Onofrio

Articles by Kaitlyn D’Onofrio

Kaitlyn D’OnofrioMesothelioma | September 21, 2023
The Food and Drug Administration (FDA) has approved NovoTTF-100L System (Novocure) in conjunction with pemetrexed plus ...
Read More
Kaitlyn D’OnofrioMesothelioma | September 21, 2023
A qualitative study took a closer look at the experiences of military veterans in the UK living with mesothelioma.
Kaitlyn D’OnofrioMesothelioma | September 21, 2023
Men and women living with mesothelioma may share similar experiences but have different concerns that nurses and other ...
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 21, 2023
Treatment with pembrolizumab plus concurrent chemoradiation therapy (cCRT) was safe and effective in patients with ...
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 21, 2023
Patients with early-stage non-small cell lung cancer (NSCLC) should not delay undergoing surgery, as waiting too long ...
Kaitlyn D’OnofrioSmall Cell Lung Cancer | September 21, 2023
Dustin Diamond, who rose to fame in the 1990s for his role as Samuel “Screech” Powers on the hit television show ...
Kaitlyn D’OnofrioSmall Cell Lung Cancer | September 21, 2023
Dustin Diamond is questioning what caused him to develop lung cancer and is reportedly speculating whether it may be the ...
Kaitlyn D’OnofrioSmall Cell Lung Cancer | September 21, 2023
Dustin Diamond, known best for his portrayal of Screech Powers on the hit 1990’s show “Saved By The Bell,” was ...
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 21, 2023
Verastem Oncology recently announced the initiation of the second phase 2 registration-directed clinical trial from its ...
Kaitlyn D’OnofrioLung Cancer | September 21, 2023
A study exploring awareness and help-seeking for potential symptoms of lung cancer among patients at high risk for the ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
Lung cancer is the leading cause of cancer deaths in the United States and is the most common cancer among men and ...
Kaitlyn D’OnofrioSmall Cell Lung Cancer | September 20, 2023
Lurbinectedin may be a viable option as a second-line treatment for small-cell lung cancer (SCLC) patients whose ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
A study of lung cancer screening programs websites found that they tend to “lack balance” in their portrayal of ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
According to a new report, black and Hispanic patients are less likely to undergo recommended PET/CT imaging upon lung ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
Current and former smokers have an increased risk for developing lung cancer compared to the general population. For ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
A randomized, clinical study compared the efficacy of a patient decision aid (PDA) about lung cancer screening versus a ...
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 20, 2023
A new study observed an independent association between high body mass index (BMI) and improved survival with ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
A new study suggests that clinical trial criteria for lung cancer patients may be excluding patients taking commonly ...
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 20, 2023
Patients with metastatic non-small cell lung cancer may not have access to certain high-cost agents depending on where ...
Kaitlyn D’OnofrioLung Cancer | September 20, 2023
A recent study of disparities in cancer care observed that older, black lung cancer patients may be less likely than ...